Cargando…
Neuraminidase 1 (NEU1) promotes proliferation and migration as a diagnostic and prognostic biomarker of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is among the most malignant cancers worldwide, lacking biomarkers for subtyping and the reliable prognostication. Herein, we report a novel biomarker, NEU1 (neuraminidase 1), is up-regulated in most samples of HCC. The diagnostic value of NEU1 was evaluated by ROC, and...
Autores principales: | Hou, Guojun, Liu, Gang, Yang, Yuan, Li, Yixue, Yuan, Shengxian, Zhao, Linghao, Wu, Mengchao, Liu, Lei, Zhou, Weiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323129/ https://www.ncbi.nlm.nih.gov/pubmed/27602751 http://dx.doi.org/10.18632/oncotarget.11778 |
Ejemplares similares
-
Potential diagnostic and prognostic marker dimethylglycine dehydrogenase (DMGDH) suppresses hepatocellular carcinoma metastasis in vitro and in vivo
por: Liu, Gang, et al.
Publicado: (2016) -
A New Approach to Evaluating Aberrant DNA Methylation Profiles in Hepatocellular Carcinoma as Potential Biomarkers
por: Yang, Yuan, et al.
Publicado: (2017) -
Novel mutations in the neuraminidase-1 (NEU1) gene in two patients of sialidosis in India
por: Ranganath, Prajnya, et al.
Publicado: (2012) -
Antibody against Microbial Neuraminidases Recognizes Human Sialidase 3 (NEU3): the Neuraminidase/Sialidase Superfamily Revisited
por: Feng, Chiguang, et al.
Publicado: (2017) -
DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334
por: Sun, Dapeng, et al.
Publicado: (2022)